Novartis AG - Company Profile and SWOT Analysis

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $175	50 Pages	MarketLine	February, 2025	MTLN19883140

Best Price Guarantee
Price	from $175
Length	50 Pages
Publisher	MarketLine
Published Date	February, 2025
SKU	MTLN19883140

Novartis AG - Company Profile and SWOT Analysis

Summary

Novartis AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Novartis AG (Novartis or 'the company') manufactures, and supplies pharmaceutical products, and generic and biosimilar medicines. The company's product portfolio includes biopharmaceuticals, ophthalmic pharmaceuticals, anti-infectives, retail generics, vision care products, generic medicines and biosimilars. It provides products for cancer, cardio metabolic, cell and gene therapy. Novartis offers its products under Alcon, Azarga, Ciprodex, Cibacen, Cosentyx, Sandoz, Votrient, DAILIES, Clear Care, AIR OPTIX, FreshLook and Lucentis brand names. It also conducts various research and development activities through its Novartis Institutes for BioMedical Research (NIBR). It has operations across Asia, Europe, the US, and Africa. The company is headquartered in Basel, Switzerland.

Scope

Detailed information on Novartis AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Novartis AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Novartis AG and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Novartis AG as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Novartis AG's business structure, strategy and prospects.

Company Snapshot: Novartis AG: Company Overview; Novartis AG: Overview and Key Facts; Novartis AG: Overview; Novartis AG: Key Facts; Novartis AG: Key Employees; Novartis AG: Key Employee Biographies; Novartis AG: Major Products and Services; Novartis AG: Management Statement; Novartis AG: Locations and Subsidiaries; Novartis AG: Key Competitors; Novartis AG: Company Analysis; Novartis AG: Business Description; Novartis AG: SWOT Analysis; Novartis AG: SWOT Overview; Novartis AG: Strengths; Novartis AG: Weaknesses; Novartis AG: Opportunities; Novartis AG: Threats; Novartis AG: Corporate Financial Deals Activity; Novartis AG: Financial Deals Overview; Novartis AG: Targets and Partners; Novartis AG: Top Deals 2021 - 2025YTD*; Novartis AG: Advisors; Novartis AG: Top Legal Advisors; Novartis AG: Top Financial Advisors; Novartis AG: Mergers and Acquisitions; Novartis AG: Corporate Venturing; Novartis AG: Partnership; Novartis AG: Divestments; Novartis AG: Recent Developments; Novartis AG: News and Events Summary; Novartis AG: Corporate Governance; Novartis AG: Financial Performance; Novartis AG: Market Developments; Novartis AG: Research & Development; Novartis AG: Strategy and Operations
Appendix: Contact Us; Methodology; About MarketLine
List of Tables: Table 1: Novartis AG: Key Facts; Table 2: Novartis AG: Key Employees; Table 3: Novartis AG: Locations and Subsidiaries; Table 4: Novartis AG: Key Competitors; Table 5: Novartis AG: Deal Activity by Deal Type - Volume (TTM*); Table 6: Novartis AG: M&A Activity by Geography (TTM*); Table 7: Novartis AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025); Table 8: Novartis AG: M&A Average Deal Size - Value (US$m); Table 9: Novartis AG: Targets and Partners; Table 10: Novartis AG: Top Deals 2021 - 2025YTD*; Table 11: Novartis AG: Legal Advisor Ranking by Value (US$m); Table 12: Novartis AG: Financial Advisor Ranking by Value (US$m); Table 13: Novartis AG: M&A Volume and Value Trend (2021 - YTD*2025); Table 14: Novartis AG: M&A Activity by Geography (2021 - YTD*2025); Table 15: Novartis AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025); Table 16: Novartis AG: Corporate Venturing by Geography (2021 - YTD*2025); Table 17: Novartis AG: Partnership Volume and Value Trend (2021 - YTD*2025); Table 18: Novartis AG: Partnership Trend by Deal Type (2021 - YTD*2025); Table 19: Novartis AG: Divestments Volume and Value Trend (2021 - YTD*2025); Table 20: Novartis AG: Divestments by Geography (2021 - YTD*2025); Table 21: Novartis AG: News and Events Summary; Table 22: Novartis AG: Corporate Governance; Table 23: Novartis AG: Financial Performance; Table 24: Novartis AG: Market Developments; Table 25: Novartis AG: Research & Development; Table 26: Novartis AG: Strategy and Operations
List of Figures: Figure 1: Novartis AG: Deal Activity by Deal Type - Volume (TTM*); Figure 2: Novartis AG: M&A Activity by Geography (TTM*); Figure 3: Novartis AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025); Figure 4: Novartis AG: M&A Average Deal Size - Value (US$m); Figure 5: Novartis AG: M&A Volume and Value Trend (2021 - YTD*2025); Figure 6: Novartis AG: M&A Activity by Geography (2021 - YTD*2025); Figure 7: Novartis AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025); Figure 8: Novartis AG: Corporate Venturing by Geography (2021 - YTD*2025); Figure 9: Novartis AG: Partnership Volume and Value Trend (2021 - YTD*2025); Figure 10: Novartis AG: Partnership Trend by Deal Type (2021 - YTD*2025); Figure 11: Novartis AG: Divestments Volume and Value Trend (2021 - YTD*2025); Figure 12: Novartis AG: Divestments by Geography (2021 - YTD*2025)